AI-generated summary
The authors report developing porphyrin-grafted lipid nanoparticles that encapsulate the chemotherapy drug doxorubicin, with an encapsulation efficiency of about 99%. In cell lines and a xenograft mouse model, they report that laser irradiation reduced cell viability and suppressed tumor growth, and that the particles accumulated in tumors and could be imaged. The abstract describes these as in vitro and in vivo experiments, without reporting sample sizes.
- Who or what was studied
- Cell lines and a xenograft mouse model; animal and cell study, not human participants
- Limits stated in the abstract
- The abstract reports only preclinical in vitro and xenograft mouse experiments and gives no sample sizes or human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on thno.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser, Reactive oxygen species. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.